伦瓦提尼
医学
依维莫司
舒尼替尼
彭布罗利珠单抗
内科学
肾细胞癌
肿瘤科
癌症
免疫疗法
甲状腺癌
作者
Robert J. Motzer,B. Yа. Alekseev,Sun Young Rha,Camillo Porta,Masatoshi Eto,Thomas Powles,Viktor Grünwald,Thomas E. Hutson,Evgeny Kopyltsov,María José Méndez-Vidal,Vadim Kozlov,Anna Alyasova,Sung‐Hoo Hong,Anil Kapoor,Teresa Alonso Gordoa,Jaime R. Merchan,Eric Winquist,Pablo Maroto,Jeffrey C. Goh,Miso Kim
标识
DOI：10.1056/nejmoa2035716
摘要
Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
不配.
Zoo
fifteen
飲啖茶食個包
eric888
镓氧锌钇铀
HZQ
缓慢的白昼
pcr163
打卡下班
Joy
梁三柏
MMMMM
夜白
糟糕的万恶
七月流火
iNk
YSM
虚拟的鼠标
CR7
皖公网安备34019202002308
